tm
Seeing Is Believing
tm
Seeing Is Believing
NRXP is currently covered by 3 analysts with an average price target of $12.83. This is a potential upside of $9.69 (308.6%) from yesterday's end of day stock price of $3.14.
NRX Pharmaceuticals's activity chart (see below) currently has 6 price targets and 13 ratings on display. The stock rating distribution of NRXP is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 180.33 days.
Highest price target for NRXP is $34, Lowest price target is $34, average price target is $34.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 21-Oct-2025. First documented stock forecast 30-Jun-2022.
Currently out of the existing stock ratings of NRXP, 6 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$34
$30.85 (979.37%)
6 days ago
(21-Oct-2025)
0/1 (0%)
$30.79 (959.19%)
Buy
5 months 28 days ago
(29-Apr-2025)
2/2 (100%)
$-1.7 (-25.37%)
137
Buy
7 months 7 days ago
(20-Mar-2025)
3/3 (100%)
$-0.01 (-0.50%)
404
What is NRXP (NRX Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on NRXP (NRX Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on NRXP (NRX Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NRXP (NRX Pharmaceuticals)?
Which analyst is the currently most bullish on NRXP (NRX Pharmaceuticals)?
Which analyst is the currently most reserved on NRXP (NRX Pharmaceuticals)?
